[1] MEHRDAD RAHMANIYAN. Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide.[J]. The Journal of Biological Chemistry, 2011: 24754-24764. DOI:
10.1074/jbc.m111.250779[2] VIVIAN R RUVOLO. Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.[J]. Journal of signal transduction, 2010: 584657. DOI:
10.1155/2010/584657[3] JA FONTANA AK R. Classical and novel retinoids: their targets in cancer therapy[J]. Leukemia, 2002, 16 4: 463-472. DOI:
10.1038/sj.leu.2402414[4] SHENGQUAN LIU. Synthesis of Flexible Sulfur-Containing Heteroarotinoids That Induce Apoptosis and Reactive Oxygen Species with Discrimination between Malignant and Benign Cells[J]. Journal of Medicinal Chemistry, 2004, 47 4: 999-1007. DOI:
10.1021/jm030346v[5] ANAT ERDREICH-EPSTEIN. Ceramide signaling in fenretinide-induced endothelial cell apoptosis.[J]. The Journal of Biological Chemistry, 2002, 277 51: 49531-49537. DOI:
10.1074/jbc.m209962200[6] BENJAMIN T BIKMAN. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis.[J]. The Journal of Biological Chemistry, 2012, 287 21: 17426-17437. DOI:
10.1074/jbc.m112.359950